0
0

Cart (0)

Home > Isotope Labelled Standards > Suplatast

Suplatast - Isotope Labelled Standards
Wishlist
Select options

Deuterated Suplatast Tosilate

  • CAT NUMBER DCTI-A-332
  • CAS NUMBER NA
  • MOLECULAR FORMULA C16H21D5NO4S+ (without salt); C23H28D5NO7S2 (p-toluenesulfonate salt)
  • MOLECULAR WEIGHT 333.48 (without salt); 504.67 (p-toluenesulfonate salt)
Select options
Wishlist
References
FAQ's

References

Bondo Hansen, John; S0ndergard Thomsen, Mikael,. H0jgaard, Bent; Composition comprising suplatast tosilate, Conrig Pharma Aps, WO 2019/042995 Α1, March 7, 2019

Frequently Asked Questions

Analytical Methods such as Reverse Phase-High Performance Liquid Chromatography (RP-HPLC) can detect impurities in Suplatast.

Suplatast impurities can impact patient safety. Depending on their nature and concentration, contaminants can cause adverse effects or reduce the efficacy of the medication.

Acetonitrile is used to achieve optimal solubility and separation of Suplatast impurities.

Suplatast impurities are stored at a controlled room temperature between 2-8 ⁰C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart